Innoviva to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference
-1m
Mustang Bio Announces Pricing of $8 Million Public Offering
-2m
-3m
Lilly reports full Q4 2024 financial results and provides 2025 guidance (Form 8-K)
-3m
-3m
Ligand to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference
-4m
A View on the Future of Healthcare Design: Q&A with Jordon Lambert
-4m
Mustang Bio Announces Pricing of $8 Million Public Offering
-4m
Voyager to Present at Oppenheimer 25th Annual Healthcare Life Sciences Conference
-4m
Philip Morris International Inc.
-5m